Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases
Disease Category: Pulmonary Arterial Hypertension

Trial Information

Randomized trial of Zocor (simvastatin) in patients with Pulmonary Hypertension

This study lasts 3 months and all patients receive study medication (Zocor or placebo) and study-related testing free of charge.

Patient Inclusion/Exclusion:

• Patients must be on Flolan (intravenous epoprostenol) or Remodulin (subcutenous eprostenol), and may be on Tracleer (bosentan).
• Pulmonary hypertension may be:
  • primary (no known association)
  • associated with connective tissue disease or congenital heart disease.

For more information,

Stanford University School of Medicine
Located in:
Stanford, CA
Phone: 650-725-8082

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.